Potential Applications of Tissue Inhibitor of Metalloproteinase (TIMP) Overexpression For Cancer Gene Therapy
- 1 January 2002
- book chapter
- Published by Springer Nature
- Vol. 465, 469-483
- https://doi.org/10.1007/0-306-46817-4_41
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Collagenase-3 (MMP-13) is Expressed by Tumor Cells in Invasive Vulvar Squamous Cell CarcinomasThe American Journal of Pathology, 1999
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell MalignancyThe Journal of cell biology, 1998
- Identification and Structural and Functional Characterization of Human Enamelysin (MMP-20),Biochemistry, 1997
- Matrix metalloproteinases in skinExperimental Dermatology, 1997
- Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4Oncogene, 1997
- Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factorsOncogene, 1997
- Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3Carcinogenesis: Integrative Cancer Research, 1996
- Matrix Metalloproteinase Matrilysin Is Constitutively Expressed in Adult Human Exocrine EpitheliumJournal of Investigative Dermatology, 1995